Top

Osteoporosis International

Published in:

01-02-2017 | Original Article

Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan

Authors: K. Moriwaki, S. Noto

Published in: Osteoporosis International | Issue 2/2017

Abstract

Summary

A model-based cost-effectiveness analysis was performed to evaluate the cost-effectiveness of secondary fracture prevention by osteoporosis liaison service (OLS) relative to no therapy in patients with osteoporosis and a history of hip fracture. Secondary fracture prevention by OLS is cost-effective in Japanese women with osteoporosis who have suffered a hip fracture.

Introduction

The purpose of this study was to estimate, from the perspective of Japan’s healthcare system, the cost-effectiveness of secondary fracture prevention by OLS relative to no therapy in patients with osteoporosis and a history of hip fracture.

Methods

A patient-level state transition model was developed to predict lifetime costs and quality-adjusted life years (QALYs) in patients with or without secondary fracture prevention by OLS. The incremental cost-effectiveness ratio (ICER) of secondary fracture prevention compared with no therapy was estimated. Sensitivity analyses were performed to examine the influence of parameter uncertainty on the base case results.

Results

Compared with no therapy, secondary fracture prevention in patients aged 65 with T-score of −2.5 resulted in an additional lifetime cost of $3396 per person and conferred an additional 0.118 QALY, resulting in an ICER of $28,880 per QALY gained. Deterministic sensitivity analyses showed that treatment duration and offset time strongly affect the cost-effectiveness of OLS. According to the results of scenario analyses, secondary fracture prevention by OLS was cost-saving compared with no therapy in patients with a family history of hip fracture and high alcohol intake.

Conclusions

Secondary fracture prevention by OLS is cost-effective in Japanese women with osteoporosis who have suffered a hip fracture. In addition, secondary fracture prevention is less expensive than no therapy in high-risk patients with multiple risk factors.

Available only for authorised users

Orimo H, Yaegashi Y, Hosoi T, Fukushima Y, Onoda T, Hashimoto T, Sakata K (2016) Hip fracture incidence in Japan: Estimates of new patients in 2012 and 25-year trends. Osteoporos Int DOI 10.1007/s00198-015-3464-8:

Orimo H, Yaegashi Y, Onoda T, Fukushima Y, Hosoi T, Sakata K (2009) Hip fracture incidence in Japan: estimates of new patients in 2007 and 20-year trends. Arch Osteoporos 4:71–77CrossRefPubMedPubMedCentral

Harada A, Matsui Y, Takemura M, Ito Z, Wakao N, Ota T (2005) Cost-utility analysis of osteoporosis. Nippon Ronen Igakkai Zasshi Japanese J Geriatrics 42:596–608CrossRef

Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14–21CrossRefPubMed

McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14:1028–1034CrossRefPubMed

Eisman JA, Bogoch ER, Dell R et al (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27:2039–2046CrossRefPubMed

Committee of Japanese Guidelines for the Prevention and Treatment of Osteoporosis (2015) The Japanese guidelines for the prevention and treatment of osteoporosis (2015 edition). Tokyo, Japan: Life Science Publishing; Japanese.

McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L, Adekunle F, Roberts D (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22:2083–2098CrossRefPubMed

Solomon DH, Patrick AR, Schousboe J, Losina E (2014) The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system. J Bone Miner Res 29:1667–1674CrossRefPubMedPubMedCentral

10.

Moriwaki K, Komaba H, Noto S, Yanagisawa S, Takiguchi T, Inoue H, Toujo T, Fukagawa M, Takahashi HE (2013) Cost-effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan. J Bone Miner Res 28:395–403CrossRefPubMed

11.

Ross PD, Fujiwara S, Huang C, Davis JW, Epstein RS, Wasnich RD, Kodama K, Melton LJ 3rd (1995) Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US. Int J Epidemiol 24:1171–1177CrossRefPubMed

12.

Fujiwara S, Kasagi F, Masunari N, Naito K, Suzuki G, Fukunaga M (2003) Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res 18:1547–1553CrossRefPubMed

13.

Hagino H, Katagiri H, Okano T, Yamamoto K, Teshima R (2005) Increasing incidence of hip fracture in Tottori Prefecture, Japan: trend from 1986 to 2001. Osteoporos Int 16:1963–1968CrossRefPubMed

14.

Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD, Fujiwara S, Hosoda Y, Melton LJ 3rd (1991) A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol 133:801–809CrossRefPubMed

15.

Soen S, Fukunaga M, Sugimoto T et al (2013) Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab 31:247–257CrossRefPubMed

16.

Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S (2010) Applied methods of cost-effectiveness analysis in healthcare. Oxford University Press, New York, USA

17.

De Laet CE, van Hout BA, Burger H, Hofman A, Pols HA (1997) Bone density and risk of hip fracture in men and women: cross sectional analysis. BMJ 315:221–225CrossRefPubMedPubMedCentral

18.

Hagino H, Furukawa K, Fujiwara S, Okano T, Katagiri H, Yamamoto K, Teshima R (2009) Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan. Osteoporos Int 20:543–548CrossRefPubMed

19.

Hagino H, Yamamoto K, Ohshiro H, Nakamura T, Kishimoto H, Nose T (1999) Changing incidence of hip, distal radius, and proximal humerus fractures in Tottori Prefecture, Japan. Bone 24:265–270CrossRefPubMed

20.

Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259CrossRefPubMedPubMedCentral

21.

Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382CrossRefPubMed

22.

Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742CrossRefPubMed

23.

Kanis JA, Johansson H, Oden A et al (2004) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029–1037CrossRefPubMed

24.

Kanis JA, Johnell O, Oden A et al (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162CrossRefPubMed

25.

Japan Ministry of Health, Labour, and Welfare. National Health and Nutrition Survey [Internet]. Tokyo, Japan: Japan Ministry of Health, Labour, and Welfare; [cited 2016 Mar 18]. Available from: http://www.mhlw.go.jp/stf/houdou/0000032074.html. Japanese. 2012.

26.

Cummings SR, Black DM, Thompson DE et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077–2082CrossRefPubMed

27.

Japan Ministry of Health, Labour, and Welfare. Life table for Japanese [Internet]. Tokyo, Japan: Japan Ministry of Health, Labour, and Welfare; [cited 2016 Mar 18]. Available from: http://www.estat.go.jp/SG1/estat/GL08020103.do?_toGL08020103_&listID=000001111987&requestSender=dsearch. Japanese 2010.

28.

Tsuboi M, Hasegawa Y, Suzuki S, Wingstrand H, Thorngren KG (2007) Mortality and mobility after hip fracture in Japan: a ten-year follow-up. J Bone Joint Surg (Br) 89:461–466CrossRef

29.

Hayashi Y (2007) Economical viewpoint for treatment of osteoporosis. Nihon Rinsho 65(9):609–614PubMed

30.

Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. NICE technology appraisal guidance [TA161] [Internet]. UK: The National Institute for Health and Care Excellence; [cited 2016 Mar 18]. Available from: https://www.nice.org.uk/guidance/ta161. 2011.

31.

Murad MH, Drake MT, Mullan RJ et al (2012) Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin Endocrinol Metab 97:1871–1880CrossRefPubMed

32.

Kanis JA, Cooper C, Hiligsmann M, Rabenda V, Reginster JY, Rizzoli R (2011) Partial adherence: a new perspective on health economic assessment in osteoporosis. Osteoporos Int 22:2565–2573CrossRefPubMed

33.

Ström O, Borgström F, Kanis JA, Jönsson B (2009) Incorporating adherence into health economic modelling of osteoporosis. Osteoporos Int 20:23–34CrossRefPubMed

34.

National Health Insurance Price List. Tokyo, Japan: Jihou Press; Japanese. 2014.

35.

Medical Fee Schedule. Tokyo, Japan: Igaku-tsushin-sya; Japanese. 2014.

36.

Kondo A, Zierler BK, Isokawa Y, Hagino H, Ito Y (2009) Comparison of outcomes and costs after hip fracture surgery in three hospitals that have different care systems in Japan. Health Policy 91:204–210CrossRefPubMed

37.

Hagino H (2002) Cost-effectiveness of the treatment for osteoporosis. Nihon Rinsho 60(3):645–654PubMed

38.

Negami S (2011) Comparison of cost for distal radius fractures before and after DPC revision by using EVE. J Sapporo Soc Insur Gen Hosp 20:43

39.

Reward for nursing care. Tokyo, Japan: Igaku-tsushin-sya; Japanese. 2014.

40.

Nawata S, Yamada Y, Ikeda S, Ikegami N (2000) EuroQol study of the elderly general population: Relationship with IADL and other attributes Journal of Health Care and Society 10:

41.

Hagino H, Nakamura T, Fujiwara S, Oeki M, Okano T, Teshima R (2009) Sequential change in quality of life for patients with incident clinical fractures: a prospective study. Osteoporos Int 20:695–702CrossRefPubMed

42.

Imai H, Fujii Y, Fukuda Y, Nakao H, Yahata Y (2008) Health-related quality of life and beneficiaries of long-term care insurance in Japan. Health Policy 85:349–355CrossRefPubMed

43.

Fukuda T, Shiroiwa T, Ikeda S et al (2013) Guideline for economic evaluation of healthcare technologies in Japan. J Natl Inst Public Health 62:625–640

44.

Gafni A, Birch S (2006) Incremental cost-effectiveness ratios (ICERs): the silence of the lambda. Soc Sci Med 62:2091–2100CrossRefPubMed

45.

Tosteson AN, Melton LJ 3rd, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, Lindsay RL (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19:437–447CrossRefPubMedPubMedCentral

46.

FRAX WHO Fracture Risk Assessment Tool. Japan - The probabilities of a major osteoporotic fracture in women [Internet]. Sheffield, UK: World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield; [cited 2016 Mar 18]. Available from: http://www.shef.ac.uk/FRAX/charts/Chart_JAP_ost_wom_bmd.pdf.

47.

Ohkusa Y, Sugawara T (2006) Research for willingness to pay for one QALY gain. Iryo To Shakai 16:157–165CrossRef

Title: Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan
Authors: K. Moriwaki
S. Noto
Publication date: 01-02-2017
Publisher: Springer London
Published in: Osteoporosis International / Issue 2/2017
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-016-3777-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2017

Effects of short-term step aerobics exercise on bone metabolism and functional fitness in postmenopausal women with low bone mass

Hypocalcaemia after denosumab in older people following fracture

Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model

Meagre effects of disuse on the human fibula are not explained by bone size or geometry

Trends in hip fracture rates in Taiwan: a nationwide study from 1996 to 2010

Impact of level of expertise versus the statistical tool on vertebral fracture assessment (VFA) readings in cohort studies